Edit ModuleShow Tags

Tech startup: KromaTiD Inc.


INITIAL LIGHT BULB: Four protechstartup-05-2011.jpgfessors from Colorado State University - Susan Bailey, Joel Bedford, Edwin Goodwin and Andrew Ray - and Michael Cornforth at University of Texas Medical Branch in Galveston, spun their decades of research into a startup to make it easier for their peers to identify genetic abnormalities.
"There's a specific aberration known as an inversion of DNA," says CEO Christopher Tompkins, a veteran of the pharmaceutical industry. "It is simply inversion of DNA in a strand, and it's very difficult to detect. It can indicate any congenital genetic disease" - i.e. anything from autism and other developmental disorders to cancer.
KromaTiD's technology - in a sense an intelligent dye - allows scientists to visually see where the DNA is - and isn't - normal.

IN A NUTSHELL: KromaTiD's innovation involves glow-in-the-dark chromosome paints that can be used to analyze a single strand of DNA at a time, ultimately delivering higher quality results at a lower price.
"What KromaTid is doing is putting together a set of tools to find specific chromosome damages," Tompkins says, describing a dye that visually indicates DNA inversions when excited under an electron microscope. Normal DNA glows, but inverted sequences do not. "If there's no damage, you have a beautiful solid purple color. Where you have damage, there's a gap. The corresponding spot lights up on the opposite strand."
Tompkins says the technology allows medical researchers "to look for a damage they've never looked for before," ultimately allowing for the development of narrowly targeted therapies.
"Once you know the gene the cause is stemming from, they can track that back to a specific enzyme or specific mechanism," Tompkins says. "We're giving (researchers) a tool to pull back one more layer."
Tompkins points to HER2-positive breast cancer as an example in which tests for the genetic marker determine the most effective therapeutic response. "They've found a very successful method of treatment," he says.
Customizable for the analysis of one to all 23 chromosomes in a single strand, KromaTiD's kits will sell for "hundreds to thousands of dollars," he adds.

THE MARKET: "The chromosome imaging market is probably $150 million a year in the U.S.," Tompkins says. He estimates a worldwide market double that figure - roughly $300 million - in turn a big piece of the "billion-dollar-ish" international market for molecular diagnostics.

FINANCING: After launching primarily with Small Business Innovation Research (SBIR) grants (as well as some funding from the state and CSU), KromaTid is currently in the market for outside capital.
"We're looking for investors right now," Tompkins says, noting that the SBIR grants and other funding will last the company at least through year's end. "We've had a lot of support."

"We're using the power of the Human Genome
Project. We know what those sequences are and should be.
The dark ages of this field were just 20 years ago."
 - KromaTiD CEO Christopher Tompkins

where: Fort Collins | FOUNDED: 2007 | www.kromatid.com
{pagebreak:Page 1}

Edit Module
Eric Peterson

Denver-based writer Eric Peterson is the author of Frommer's Colorado, Frommer's Montana & Wyoming, Frommer's Yellowstone & Grand Teton National Parks and the Ramble series of guidebooks, featuring first-person travelogues covering everything from atomic landmarks in New Mexico to celebrity gone wrong in Hollywood. Peterson has also recently written about backpacking in Yosemite, cross-country skiing in Yellowstone and downhill skiing in Colorado for such publications as Denver's Westword and The New York Daily News. He can be reached at Eptcb126@msn.com

Get more content like this: Subscribe to the magazine | Sign up for our Free e-newsletter

Edit ModuleShow Tags

Archive »Related Articles

Key to growth: A relationship with your lender

It isn’t a secret – Colorado’s economy is vibrant and strong. New developments continue to spring up across the state, many entrepreneurs have started new businesses, and many more companies are growing and need resources to meet their increased demand. What’s the secret to ensure business owners...

Do we need a new word for entrepreneur?

Has the word entrepreneur become too trendy as to have lost its meaning? I’m hearing it and the word entrepreneurship being used in so many conversations incorrectly. I’m critical of the use of the word "entrepreneur"...are you?

Hot tips for emerging company boards

Emerging companies comprise a significant portion of Colorado businesses. Venture capitalists, angel investors and founders make up the shareholders and the boards of directors of many of these companies. I spoke recently to Fran Wheeler, a partner in the Business Department of the Colorado Office...
Edit ModuleShow Tags
Edit ModuleEdit ModuleShow Tags
Edit ModuleShow Tags Edit ModuleShow Tags
Edit ModuleShow Tags Edit ModuleShow Tags
Edit ModuleShow Tags Edit ModuleShow Tags